We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

THE BINDING SITE

Engages in the research, development, manufacture, and distribution of immunodiagnostic assays, as wel as specialized... read more Featured Products: More products

Download Mobile App





Binding Site Showcases Optilite System for Special Protein Testing

By LabMedica International staff writers
Posted on 22 May 2023

Binding Site (Birmingham, UK) is showcasing its Optilite system, the leading solution for multiple myeloma and immune status testing, at the 2023 EuroMedLab Congress. More...

Optilite represents a significant breakthrough in special protein testing. The innovative system has been fully optimized to simplify complex analytical processes, delivering unparalleled efficiency, workflow optimization, and confidence in test results. With an array of intelligent features, Optilite sets a new standard in the protein laboratory field by seamlessly integrating cutting-edge technology and advanced software.

At EuroMedLab Rome 2023, Binding Site is also presenting its range of in vitro assays, which have received the CE mark for Europe, FDA clearance for the USA, and approval from regulatory authorities in multiple countries. These comprehensive assays cover all five isotypes of immunoglobulins, offering a complete solution. Among the assays being highlighted by Binding Site at the industry event are Freelite and Hevylite, which provide a comprehensive monitoring solution for managing patients with multiple myeloma.

The Freelite assay has significantly enhanced laboratory and clinical practices in the detection and follow-up of monoclonal gammopathies. The Optilite Freelite assay, FDA-cleared for aiding in the diagnosis and monitoring of multiple myeloma, represents the state-of-the-art in free light chain testing. Additionally, Hevylite is a unique immunoassay panel designed to accurately identify and quantify immunoglobulin heavy and light chain isotypes. Together, these advancements by Binding Site contribute to the advancement of diagnostic and monitoring capabilities in the field of multiple myeloma.

Related Links:
Binding Site 


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Whole Blood Control
Lyphochek Whole Blood Control
New
Hemoglobin Stool Test
CerTest FOB 50 + 200 One Step Combo Card Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Schematic overview of the deep learning-based circulating exosome analysis for lung cancer detection (Photo courtesy of Chuan Xu, Cheng Jiang)

Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer

Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more

Pathology

view channel
Image: The Aiforia Breast Cancer Grading AI solution is CE-IVD marked (Photo courtesy of Aiforia Technologies)

Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy

Labs that use traditional image analysis methods often suffer from bottlenecks and delays. By digitizing their pathology practices, labs can streamline their work, allowing them to take on larger caseloads... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.